查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610876

正壓呼吸器的全球市場:洞察，競爭情形，市場預測:2030年

Positive Airway Pressure Device - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023 年氣道正壓通氣裝置市場規模為 19.2 億美元。預計到 2030 年，該市場將達到 31.2 億美元，2024 年至 2030 年的預測期間複合年增長率為 8.40%。阻塞性睡眠呼吸中止症和慢性阻塞性肺病等慢性呼吸系統疾病的盛行率不斷上升，推動了對氣道正壓通氣設備的需求。氣道正壓通氣裝置的工作原理是提供連續或可變的氣流，以保持氣道開放並確保足夠的通風。此外，新生兒呼吸窘迫症候群也是早產兒的常見病症，其肺部尚未發育完全，需要氣道正壓裝置提供足夠的氧氣供應，正在擴大其市場。此外，非侵入性通氣，包括各種形式的氣道正壓治療，可以提供舒適感並降低與有創機械通氣相關的併發症的風險。這一趨勢進一步推動了對氣道正壓通氣設備的需求。此外，意識和篩檢計劃促進早期診斷和治療，而持續的產品開發可確保氣道正壓設備滿足不斷變化的患者和醫療保健需求。由於這些綜合因素的綜合作用，預計氣道正壓裝置市場在 2024 年至 2030 年的預測期內將在全球範圍內強勁擴張。

根據澳洲健康與福利研究所提供的最新數據，預計2022年澳洲約有850萬人（34%）患有慢性呼吸道疾病。

此外，根據《全球疾病負擔》（2023）提供的最新數據，全球大約每 20 人中就有 1 人患有慢性呼吸道疾病。

正壓呼吸機，包括持續性正壓呼吸器 (CPAP) 和雙水平氣道正壓通氣 (BiPAP)，因此為我們提供了重要的支援。由於人口老化、污染加劇、生活型態改變等因素，全球慢性呼吸道疾病發生率不斷增加，對氣道正壓通氣裝置的需求也隨之增加。

此外，該公司正在擴大氣道正壓裝置的生產並獲得監管部門的批准，以策略性地擴大其市場佔有率並推動進一步成長。例如，2024 年 2 月，ResMed 推出了一款新型雙水平睡眠呼吸中止設備，作為 CPAP 的替代品。

因此，上述因素可能會在預測期內推動氣道正壓裝置市場的發展。

本報告提供全球正壓呼吸器市場相關調查，提供市場概要，以及各設備類型，各年齡層，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 正壓呼吸器市場報告的簡介

第2章 正壓呼吸器市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 正壓呼吸器市場主要原因分析

  • 正壓呼吸器的市場促進因素
  • 正壓呼吸器的市場阻礙因素與課題
  • 正壓呼吸器的市場機會

第6章 正壓呼吸器市場波特的五力分析

第7章 正壓呼吸器市場評估

  • 各設備類型
  • 各年齡層
  • 各終端用戶
  • 各地區

第8章 正壓呼吸裝置市場企業與產品簡介

  • ResMed
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Limited.
  • APEX MEDICAL CORP
  • ARMSTRONG MEDICAL (an EAKIN Company)
  • Smiths Medical
  • Compumedics Limited
  • VYAIRE MEDICAL, INC.
  • Somnera Inc.
  • 3B Medical Inc
  • DeVilbiss Healthcare LLC
  • Curative Medical Inc.
  • Somnetics International, Inc.
  • Lowenstein Medical UK Ltd.
  • Beijing Aeonmed Co., Ltd.
  • Medin Medical Innovations GmbH
  • medicraft
  • Hebei Topson Medical Technology Ltd.
  • Sefam
  • Lowenstein Medical Technology GmbH + Co. KG

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0091

Positive Airway Pressure Devices by Device Type (Continuous Positive Airway Pressure Devices, Auto titrating Positive Airway Pressure Devices, and Bi-level Positive Airway Pressure Devices, and Others), Age Group (Adults and Pediatrics), End-User (Hospitals, Clinics, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of sleep apnea and chronic respiratory disorders, growing cases of neonatal respiratory distress syndrome, rising demand for non-invasive ventilation, increasing awareness and screening programs, and increase in product development activities by key market players across the globe.

The positive airway pressure devices market was valued at USD 1.92 billion in 2023, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030. The increasing prevalence of obstructive sleep apnea and chronic respiratory conditions, such as chronic obstructive pulmonary disease, drives the demand for positive airway pressure devices as they work by delivering a continuous or variable flow of air to keep the airway open and ensure adequate ventilation. Additionally, neonatal respiratory distress syndrome also escalate the market of these devices as it is a condition commonly seen in premature infants, where their lungs are not fully developed and hence these conditions require positive airway pressure devices for sufficient supply of oxygen. Furthermore, non-invasive ventilation, including various forms of positive airway pressure therapy, offers comfort and reduces the risk of complications associated with invasive mechanical ventilation. This trend further drives the demand for positive airway pressure devices. Moreover, increased awareness and screening programs facilitate early diagnosis and treatment, while continuous product development ensures that positive airway pressure devices meet evolving patient and healthcare needs. This comprehensive combination of factors are expected to contribute to a robust and expanding market for positive airway pressure devices globally during the forecast period from 2024 to 2030.

Positive Airway Pressure Devices Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffers from chronic respiratory diseases.

Thus, positive air pressure devices, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP), offer critical support by delivering consistent airflow to keep the airways open and ensure proper ventilation. As the global incidence of chronic respiratory diseases rises, driven by factors such as aging populations, increasing pollution, and lifestyle changes, the demand for positive airway pressure devices correspondingly grows.

Furthermore, according to the recent data provided by the Global Burden of Disease, in 2021, particulate matter air pollution accounted for approximately 8% of the total disease burden. Additionally, air pollution was responsible for about 48% of chronic obstructive pulmonary disease (COPD) cases, and around 34% of preterm births were attributed to exposure to air pollution.

Non-invasive ventilation methods, such as Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP), are designed to be more comfortable than invasive ventilation methods. Improved device design, including softer masks, quieter operation, and adjustable pressure settings, enhances patient comfort and increases adherence to therapy. Non-invasive ventilation is increasingly used in various clinical settings beyond obstructive sleep apnea (OSA), such as in managing chronic obstructive pulmonary disease (COPD), acute respiratory distress, and certain types of heart failure. This expansion of clinical applications broadens the market for positive airway pressure devices, as they become integral in managing a wider range of respiratory conditions.

Additionally, companies are amplifying their production of positive airway pressure devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in Feburary, 2024, ResMed launched new bi-level sleep apnea device as CPAP alternative.

Thus, the factors mentioned above are likely to boost the market of positive airway pressure devices during the forecasted period.

However, the side effects associated with positive airway devices such as dry mouth, nasal congestion, or sinus infection, and stringent regulatory concerns for product approval may hinder the future market of positive airway pressure devices.

Positive Airway Pressure Devices Market Segment Analysis:

Positive Airway Pressure Devices by Device Type (Continuous Positive Airway Pressure Devices, Auto titrating Positive Airway Pressure Devices, and Bi-level Positive Airway Pressure Devices, and Others), Age Group (Adults and Pediatrics), End-User (Hospitals, Clinics, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of positive airway pressure devices market the continuous positive airway pressure device are expected to hold a significant share in 2023. Continuous positive airway pressure devices are a cornerstone in the positive airway pressure market, and their impact on boosting the overall market is substantial. This can be attributed to the fact that continuous positive airway pressure devices are prescribed as the first line of positive airway pressure therapy to patients. Another factor that adds to their popularity is the simplistic design of the device, which provides a steady pressure rate for both inhalation and exhalation. Furthermore, as continuous positive airway pressure devices have the most basic design and functionality, they cost significantly less than the counterparts, thereby contributing in their increased demand in the positive airway pressure devices market. Moreover, compared to other types of positive airway pressure devices, continuous positive airway pressure devices are covered by majority of the insurance providers which further add to their popularity among end users.

Furthermore, continuous innovations in continuous positive airway pressure technology enhance the performance, comfort, and user-friendliness of these devices. Modern continuous positive airway pressure devices come with features like automatic pressure adjustments, integrated humidification, quieter operation, and connectivity with mobile apps for remote monitoring. These advancements not only improve patient compliance but also stimulate market growth by attracting new customers and retaining existing users.

Additionally, the increasing product development activites in the continuous positive airway pressure devices market can significantly boost the overall market of positive airway pressure devices by improving patient outcomes, meeting diverse needs, and enhancing clinical outcomes. For instance, in September 2021, Koninklijke Philips N.V received the authorization from the US Food and Drug Administration for the initiation of the repairing of their first-generation DreamStation CPAP devices. These devices were previously recalled in June 2021 due to probable health issues in patients.

Therefore, owing to the above-mentioned factors, the continuous positive airway pressure devices category is expected to generate considerable revenue thereby pushing the overall growth of the global positive airway pressure devices market during the forecast period.

North America is expected to dominate the overall positive airway pressure devices market:

North America is expected to account for the highest proportion of the positive airway pressure devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease across the region, increase government initiatives coupled with increased awareness programs for respiratory disorders, increase in preterm birth rate where their lungs are not fully developed and require immediate oxygen support, and the presence of key market players engaged in merges, acquisition, product launches, and other market activities across the region are expected to escalate the market of positive airway pressure devices during the forecast period.

As per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States.

Furthermore, as per the recent data and stats provided by the State of Sleep Health in America (2023), sleep apnea affects about 20% of U.S adults, in which 90% of adults are undiagnosed. Additionally, as per the recent data provided by the National Council of Aging (2024), approximately 39 million U.S. adults have obstructive sleep apnea (OSA).

These devices, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, are essential for treating these conditions by providing the necessary airflow to keep the airways open and prevent interruptions in breathing. The growing number of diagnosed cases leads to a larger patient population seeking treatment, which in turn drives market growth across the region.

Furthermore, the increase in preterm birth rate are also propelling the overall market of positive airway pressure across the region. As per the recent data provided by the Centre for Disease Control and Prevention (2024), the preterm birth rate increased by 4% from 2020 to 2021. However, racial and ethnic disparities in preterm birth rates persisted. In 2022, the preterm birth rate among Black women was 14.6%, approximately 50% higher than the rates among White women, who had a rate of 9.4%, and Hispanic women, who had a rate of 10.1%. Preterm infants are more likely to experience conditions like neonatal respiratory distress syndrome (NRDS) and other respiratory complications that require immediate intervention.

The increasing number of product development activities in the region is further going to accelerate the growth of the positive airway pressure devices market. For example, In February 2021, 3B Medical Inc., received the product approval from US Food and Drug Administration for their new third generation bi-level device- Luna G3 Auto-BPAP device. The device is indicated to be used in the treatment of obstructive sleep apnea.

Therefore, the above-mentioned factors are expected to bolster the growth of the positive airway pressure devices market in the North America during the forecast period.

Positive Airway Pressure Devices Market Key Players:

Some of the key market players operating in the positive airway pressure devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG, and others.

Recent Developmental Activities in the Positive Airway Pressure Devices Market:

  • In July 2024, VARON enters CPAP and BiPAP machine market with feature-rich "Sunny Grand" series. VARON's SUNNY GRAND Series boasts two feature-packed models, the 20A CPAP and the 25S BiPAP, catering to a wide range of sleep apnea severities and user preferences.
  • In August 2021, ResMed launched AirSense 11 PAP Series, the company's next-generation PAP device for sleep apnea management. The device includes features such as Care-In and Personal Therapy Assistant among other features.

Key Takeaways From the Positive Airway Pressure Devices Market Report Study:

  • Market size analysis for current positive airway pressure devices size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the positive airway pressure devices market.
  • Various opportunities available for the other competitors in the positive airway pressure devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current positive airway pressure devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for positive airway pressure devices market growth in the coming future?

Target Audience who can be Benefited From This Positive Airway Pressure Devices Market Report Study:

  • Positive airway pressure devices product providers
  • Research organizations and consulting companies
  • Positive airway pressure devices -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in positive airway pressure devices
  • Various end-users who want to know more about the positive airway pressure devices market and the latest technological developments in the positive airway pressure devices market.

Frequently Asked Questions for the Positive Airway Pressure Devices Market:

1. What are positive airway pressure devices?

Positive airway pressure devices help in keeping the airways open for sleep apnea patients and prevent it from collapsing while they sleep thereby enabling them to breathe normally.

2. What is the market for positive airway pressure devices?

The positive airway pressure devices market was valued at USD 1.92 billion in 2023, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030.

3. What are the drivers for the positive airway pressure devices market?

The increasing prevalence of obstructive sleep apnea and chronic respiratory conditions, such as chronic obstructive pulmonary disease, drives the demand for positive airway pressure devices as they work by delivering a continuous or variable flow of air to keep the airway open and ensure adequate ventilation. Additionally, neonatal respiratory distress syndrome also escalate the market of these devices as it is a condition commonly seen in premature infants, where their lungs are not fully developed and hence these conditions require positive airway pressure devices for sufficient supply of oxygen. Furthermore, non-invasive ventilation, including various forms of positive airway pressure therapy, offers comfort and reduces the risk of complications associated with invasive mechanical ventilation. This trend further drives the demand for positive airway pressure devices. Moreover, increased awareness and screening programs facilitate early diagnosis and treatment, while continuous product development ensures that positive airway pressure devices meet evolving patient and healthcare needs. This comprehensive combination of factors are expected to contribute to a robust and expanding market for positive airway pressure devices globally during the forecast period from 2024 to 2030.

4. Who are the key players operating in the positive airway pressure devices market?

Some of the key market players operating in the positive airway pressure devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Lowenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Lowenstein Medical Technology GmbH + Co. KG, and others.

5. Which region has the highest share in the positive airway pressure devices market?

North America is expected to account for the highest proportion of the positive airway pressure devices market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease across the region, increase government initiatives coupled with increased awareness programs for respiratory disorders, increase in preterm birth rate where their lungs are not fully developed and require immediate oxygen support, and the presence of key market players engaged in merges, acquisition, product launches, and other market activities across the region are expected to escalate the market of positive airway pressure devices during the forecast period.

Table of Contents

1. Positive Airway Pressure Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Positive Airway Pressure Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Positive Airway Pressure Devices Market Key Factors Analysis

  • 5.1. Positive Airway Pressure Devices Market Drivers
    • 5.1.1. The rising burden of sleep apnea and chronic respiratory disorders
    • 5.1.2. Growing cases of neonatal respiratory distress syndrome
    • 5.1.3. Rising demand for non-invasive ventilation
    • 5.1.4. Increasing awareness and screening programs
    • 5.1.5. Increase in product development activities by key market players across the globe.
  • 5.2. Positive Airway Pressure Devices Market Restraints and Challenges
    • 5.2.1. The side effects associated with positive airway devices such as dry mouth, nasal congestion, or sinus infection
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Positive Airway Pressure Devices Market Opportunities
    • 5.3.1. Ongoing innovations in PAP technology, such as smart devices with integrated sensors, real-time data monitoring, and connectivity with mobile health apps,

6. Positive Airway Pressure Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Positive Airway Pressure Devices Market Assessment

  • 7.1. By Device Type
    • 7.1.1. CPAP Devices
    • 7.1.2. APAP Devices
    • 7.1.3. BiPAP Devices
    • 7.1.4. Others
  • 7.2. By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Home Settings
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Positive Airway Pressure Devices Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Positive Airway Pressure Devices Market Size in USD Million (2021-2030)

8. Positive Airway Pressure Devices Market Company and Product Profiles

  • 8.1. ResMed
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Fisher & Paykel Healthcare Limited.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. APEX MEDICAL CORP
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. ARMSTRONG MEDICAL (an EAKIN Company)
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Smiths Medical
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Compumedics Limited
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. VYAIRE MEDICAL, INC.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Somnera Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. 3B Medical Inc
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. DeVilbiss Healthcare LLC
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Curative Medical Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Somnetics International, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Lowenstein Medical UK Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Beijing Aeonmed Co., Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Medin Medical Innovations GmbH
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. medicraft
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Hebei Topson Medical Technology Ltd.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Sefam
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Lowenstein Medical Technology GmbH + Co. KG
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Positive Airway Pressure Devices Market in Global (2021-2030)
  • Table 3: Positive Airway Pressure Devices Market in Global by Device Type (2021-2030)
  • Table 4: Positive Airway Pressure Devices Market in Global by Age Group (2021-2030)
  • Table 5: Positive Airway Pressure Devices Market in Global by End-User (2021-2030)
  • Table 6: Positive Airway Pressure Devices Market in Global by Geography (2021-2030)
  • Table 7: Positive Airway Pressure Devices Market in North America (2021-2030)
  • Table 8: Positive Airway Pressure Devices Market in the United States (2021-2030)
  • Table 9: Positive Airway Pressure Devices Market in Canada (2021-2030)
  • Table 10: Positive Airway Pressure Devices Market in Mexico (2021-2030)
  • Table 11: Positive Airway Pressure Devices Market in Europe (2021-2030)
  • Table 12: Positive Airway Pressure Devices Market in France (2021-2030)
  • Table 13: Positive Airway Pressure Devices Market in Germany (2021-2030)
  • Table 14: Positive Airway Pressure Devices Market in United Kingdom (2021-2030)
  • Table 15: Positive Airway Pressure Devices Market in Italy (2021-2030)
  • Table 16: Positive Airway Pressure Devices Market in Spain (2021-2030)
  • Table 17: Positive Airway Pressure Devices Market in the Rest of Europe (2021-2030)
  • Table 18: Positive Airway Pressure Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Positive Airway Pressure Devices Market in China (2021-2030)
  • Table 20: Positive Airway Pressure Devices Market in Japan (2021-2030)
  • Table 21: Positive Airway Pressure Devices Market in India (2021-2030)
  • Table 22: Positive Airway Pressure Devices Market in Australia (2021-2030)
  • Table 23: Positive Airway Pressure Devices Market in South Korea (2021-2030)
  • Table 24: Positive Airway Pressure Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Positive Airway Pressure Devices Market in the Rest of the World (2021-2030)
  • Table 26: Positive Airway Pressure Devices Market in the Middle East (2021-2030)
  • Table 27: Positive Airway Pressure Devices Market in Africa (2021-2030)
  • Table 28: Positive Airway Pressure Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Positive Airway Pressure Devices Market in Global (2021-2030)
  • Figure 3: Positive Airway Pressure Devices Market in Global by Device Type (2021-2030)
  • Figure 4: Positive Airway Pressure Devices Market in Global by Age Group (2021-2030)
  • Figure 5: Positive Airway Pressure Devices Market in Global by End-User (2021-2030)
  • Figure 6: Positive Airway Pressure Devices Market in Global by Geography (2021-2030)
  • Figure 7: Positive Airway Pressure Devices Market in North America (2021-2030)
  • Figure 8: Positive Airway Pressure Devices Market in the United States (2021-2030)
  • Figure 9: Positive Airway Pressure Devices Market in Canada (2021-2030)
  • Figure 10: Positive Airway Pressure Devices Market in Mexico (2021-2030)
  • Figure 11: Positive Airway Pressure Devices Market in Europe (2021-2030)
  • Figure 12: Positive Airway Pressure Devices Market in France (2021-2030)
  • Figure 13: Positive Airway Pressure Devices Market in Germany (2021-2030)
  • Figure 14: Positive Airway Pressure Devices Market in United Kingdom (2021-2030)
  • Figure 15: Positive Airway Pressure Devices Market in Italy (2021-2030)
  • Figure 16: Positive Airway Pressure Devices Market in Spain (2021-2030)
  • Figure 17: Positive Airway Pressure Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Positive Airway Pressure Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Positive Airway Pressure Devices Market in China (2021-2030)
  • Figure 20: Positive Airway Pressure Devices Market in Japan (2021-2030)
  • Figure 21: Positive Airway Pressure Devices Market in India (2021-2030)
  • Figure 22: Positive Airway Pressure Devices Market in Australia (2021-2030)
  • Figure 23: Positive Airway Pressure Devices Market in South Korea (2021-2030)
  • Figure 24: Positive Airway Pressure Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Positive Airway Pressure Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Positive Airway Pressure Devices Market in the Middle East (2021-2030)
  • Figure 27: Positive Airway Pressure Devices Market in Africa (2021-2030)
  • Figure 28: Positive Airway Pressure Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis